Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.840
-0.040 (-1.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $120.73 million as of November 21, 2024. Its market cap has decreased by -34.37% in one year.
Market Cap
120.73M
Enterprise Value
-56.14M
1-Year Change
-34.37%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $120.73M, a decrease of -87.23%. That is a compound annual growth rate of -37.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 122.43M | -60.19% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 125.62M |
| Outlook Therapeutics | 124.19M |
| Avalo Therapeutics | 123.69M |
| TriSalus Life Sciences | 123.49M |
| Protalix BioTherapeutics | 123.18M |
| Alto Neuroscience | 120.56M |
| Vigil Neuroscience | 120.53M |
| Cabaletta Bio | 119.68M |